BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31348196)

  • 1. An Evaluation of Hepatitis C Virus Telehealth Services Serving Tribal Communities: Patterns of Usage, Evolving Needs, and Barriers.
    Stephens D; Leston J; Terrault NA; Gailloux K; Mera J; Essex W; Reilley B
    J Public Health Manag Pract; 2019; 25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years():S97-S100. PubMed ID: 31348196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of treatment access and scope of a multistate hepatitis C virus Extension for Community Healthcare Outcomes telehealth service in the US Indian Health System, 2017-2021.
    Wirth AN; Cushman NA; Reilley BA; Leston JD; Mera JR; Levander XA; Stephens DJ
    J Rural Health; 2023 Mar; 39(2):358-366. PubMed ID: 36526593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Regional Analysis of Hepatitis C Virus Collaborative Care With Pharmacists in Indian Health Service Facilities.
    Geiger R; Steinert J; McElwee G; Carver J; Montanez R; Niewoehner J; Clark C; Reilley B
    J Prim Care Community Health; 2018; 9():2150132718807520. PubMed ID: 30348039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial for a peer-facilitated telemedicine hepatitis c treatment intervention for people who use drugs in rural communities: study protocol for the "peer tele-HCV" study.
    Herink MC; Seaman A; Leichtling G; Larsen JE; Gailey T; Cook R; Thomas A; Korthuis PT
    Addict Sci Clin Pract; 2023 May; 18(1):35. PubMed ID: 37245041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ECHO model proved to be a useful tool to increase clinicians' self-effectiveness for care of patients with Hepatitis C in Argentina.
    Mendizabal M; Ridruejo E; Ceballos S; Sixto M; Billordo A; Gadea C; Mengarelli S; Alonso C; Palazzo A; De María L; Bruno A; Perez D; Piñero F; Deltrozzo V; Mendoza C; Figueroa S; Manero E; Villa M; Barreyro F; Moreno V; Vilar J; Murga D; Fernandez M; O Flaherty M; Arora S; Silva M;
    J Viral Hepat; 2019 Nov; 26(11):1284-1292. PubMed ID: 31273860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
    Lebovics E; Torres R; Porter LK
    Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding access to hepatitis C virus treatment--Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care.
    Arora S; Kalishman S; Thornton K; Dion D; Murata G; Deming P; Parish B; Brown J; Komaromy M; Colleran K; Bankhurst A; Katzman J; Harkins M; Curet L; Cosgrove E; Pak W
    Hepatology; 2010 Sep; 52(3):1124-33. PubMed ID: 20607688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECHO+: Improving access to hepatitis C care within Indigenous communities in Alberta, Canada.
    Dunn KP; Williams KP; Egan CE; Potestio ML; Lee SS
    Can Liver J; 2022; 5(2):113-123. PubMed ID: 35991479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the Extension for Community Healthcare Outcomes Project With Use of Direct-Acting Antiviral Treatment Among US Adults With Hepatitis C.
    Tran L; Feldman R; Riley T; Jung J
    JAMA Netw Open; 2021 Jul; 4(7):e2115523. PubMed ID: 34213557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model--Arizona and Utah, 2012-2014.
    Mitruka K; Thornton K; Cusick S; Orme C; Moore A; Manch RA; Box T; Carroll C; Holtzman D; Ward JW;
    MMWR Morb Mortal Wkly Rep; 2014 May; 63(18):393-8. PubMed ID: 24807237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telementoring for hepatitis C treatment in correctional facilities.
    Neuhaus M; Langbecker D; Caffery LJ; Taylor M; Garner L; Williams G; Smith AC; Macdonald GA
    J Telemed Telecare; 2018 Dec; 24(10):690-696. PubMed ID: 30343659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Training the healthcare workforce: the global experience with telementorship for hepatitis B and hepatitis C.
    Corcorran MA; Thornton K; Struminger B; Easterbrook P; Scott JD
    BMC Health Serv Res; 2023 Aug; 23(1):824. PubMed ID: 37533025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to the Treatment of Hepatitis C among Predominantly African American Patients Seeking Care in an Urban Teaching Hospital in Washington, D.C.
    Liu L; Daftary MN; Alzahrani MS; Ohanele C; Maneno MK
    J Natl Med Assoc; 2021 Apr; 113(2):147-157. PubMed ID: 32868101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using telehealth to improve access to hepatitis C treatment in the direct-acting antiviral therapy era.
    Schulz TR; Kanhutu K; Sasadeusz J; Watkinson S; Biggs BA
    J Telemed Telecare; 2020 Apr; 26(3):180-185. PubMed ID: 30336724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enablers and barriers for the provision of community-based HCV treatment: A case study of a real-world practice.
    Pourmarzi D; Smirnov A; Hall L; Thompson H; FitzGerald G; Rahman T
    J Viral Hepat; 2020 May; 27(5):484-496. PubMed ID: 31958355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Framework for community-based models for treating hepatitis C virus.
    Pourmarzi D; Hall L; Smirnov A; Hepworth J; Rahman T; FitzGerald G
    Aust Health Rev; 2020 Jun; 44(3):459-469. PubMed ID: 31671288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
    Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C services at harm reduction centres in the European Union: a 28-country survey.
    Pericàs JM; Bromberg DJ; Ocampo D; Schatz E; Wawer I; Wysocki P; Safreed-Harmon K; Lazarus JV
    Harm Reduct J; 2019 Mar; 16(1):20. PubMed ID: 30898122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region.
    Sherbuk JE; Knick TK; Canan C; Ross P; Helbert B; Cantrell ES; Cantrell CJ; Stallings R; Barron N; Jordan D; McManus KA; Dillingham R
    J Infect Dis; 2020 Sep; 222(Suppl 5):S354-S364. PubMed ID: 32877562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.